Skip to content
  • Blog
  • Why Biomarkers?
  • Contact
Nordic Bioscience
Mobile Site Logo
    • Biomarker Solutions

      Learn how Nordic ProteinFingerPrint™ biomarkers can support your pipeline.

      Visit this section
    • Biomarker Portfolio

      Find biomarkers and panels relevant to your study.

      Visit this section
    • Why Biomarkers?

      Learn how biomarkers in general can benefit drug development.

      Visit this section

      Therapeutic areas

    • Cardiovascular diseases

      Browse overview
      • Atherosclerosis and myocardial infarction
      • Cardiomyopathies
      • Heart failure
    • Dermatology

      Browse overview
      • Atopic dermatitis
      • Hidradenitis suppurutiva
      • Psoriasis
      • Psoriatic arthritis
      • Scleroderma (systemic sclerosis)
      • Translational models in dermatology
    • Gastrointestinal diseases

      Browse overview
      • CPa9-HNE (NordicCPa9-HNE™)—serum calprotectin
      • Inflammatory bowel disease (IBD)
      • Crohn’s disease
      • Ulcerative colitis
      • Intestinal fibrosis
      • Celiac disease
      • Eosinophilic esophagitis (EoE)
      • Translational models in IBD
    • Hepatic diseases

      Browse overview
      • Alcohol-related liver disease
      • End-stage liver disease
      • Enhanced Liver Fibrosis (ELF) Test
      • Immune-mediated liver diseases
      • MASLD, SLD, and MASH
      • Metabolic dysregulation
      • Viral liver diseases
      • Translational models in hepatic fibrosis
    • Kidney diseases

      Browse overview
      • Chronic kidney disease (CKD)
      • IgA nephropathy (Berger’s disease)
      • Diabetic kidney disease (DKD)
      • Lupus nephritis
      • Translational models in kidney diseases
    • Neuroscience

      Browse overview
      • Alzheimer’s disease
      • Parkinson’s disease
      • Multiple sclerosis
    • Obesity

      Browse overview
      • Obesity
      • Diabetes
      • Enhanced Liver Fibrosis (ELF) Test
    • Oncology

      Browse overview
      • Immuno-oncology
      • Tumor fibrosis
      • Cancer-associated Fibroblasts (CAFs)
      • Translational models in cancer
    • Respiratory diseases

      Browse overview
      • Chronic respiratory diseases
      • ECLIPSE partnering project (COPD)
      • Pulmonary fibrosis
      • Translational models in pulmonary fibrosis
    • Rheumatic diseases

      Browse overview
      • Axial spondyloarthritis (axSpA)
      • Osteoarthritis (OA)
      • Psoriatic arthritis
      • Rheumatoid arthritis (RA)
      • RheumaTrace™
      • Systemic lupus erythematosus (SLE)
      • Systemic sclerosis
      • Translational models in rheumatology

    What we offer

    Biomarker portfolio

    Browse our extensive ProteintFingerPrint™ biomarker portfolio and easily find the biomarkers and biomarker panels that are most relevant to your study. 

    Explore our biomarker portfolio
    • Biomarker Solutions

      Learn how Nordic ProteinFingerPrint™ biomarkers can support your pipeline.

      Visit this section
    • Biomarker Portfolio

      Find biomarkers and panels relevant to your study.

      Visit this section
    • Why Biomarkers?

      Learn how biomarkers in general can benefit drug development.

      Visit this section

      Our lab solutions

    • Browse overview
    • Why choose our lab
    • Central lab services
    • Specialty lab solutions
    • Accreditations
    • Regulatory services

    Our services

    Lab solutions

    Browse our comprehensive laboratory services and discover specialized solutions tailored to your research needs.

    Explore our lab services
    • Biomarker Solutions

      Learn how Nordic ProteinFingerPrint™ biomarkers can support your pipeline.

      Visit this section
    • Biomarker Portfolio

      Find biomarkers and panels relevant to your study.

      Visit this section
    • Why Biomarkers?

      Learn how biomarkers in general can benefit drug development.

      Visit this section

      Technology

    • Browse overview
    • Nordic ProteinFingerPrint Technology™
    • FIB-NIT™ biomarker panel
    • RheumaTrace™
    • NordicPRO-C3™ (PRO-C3)
    • CPa9-HNE (NordicCPa9-HNE™)—serum calprotectin
    • Translational models

    Measure specific protein fragments

    Our technology

    Utilize Nordic Bioscience's ProteinFingerPrint™ biomarker technology to measure specific protein fragments.

    Take a look at our technology
    • Biomarker Solutions

      Learn how Nordic ProteinFingerPrint™ biomarkers can support your pipeline.

      Visit this section
    • Biomarker Portfolio

      Find biomarkers and panels relevant to your study.

      Visit this section
    • Why Biomarkers?

      Learn how biomarkers in general can benefit drug development.

      Visit this section

      About

    • Browse overview
    • About us
    • News & events
    • Board of directors
    • Scientific leadership
    • Business development
    • Vision, mission & values
    • Career

    About Nordic Bioscience

    Who we are

    Learn about our history, leadership, and vision for the future. Stay updated with the latest news and events, discover career opportunities, and see how our expertise and strategic alliances shape the future of science.

    Explore Nordic Bioscience
  • Publications
  • Request a quote

Menu

  • Biomarker Solutions
    • Biomarker Solutions

      Learn how Nordic ProteinFingerPrint™ biomarkers can support your pipeline.

      Visit this section
    • Biomarker Portfolio

      Find biomarkers and panels relevant to your study.

      Visit this section
    • Why Biomarkers?

      Learn how biomarkers in general can benefit drug development.

      Visit this section
    • Cardiovascular diseases

      Cardiovascular diseases

      Browse overview
      • Atherosclerosis and myocardial infarction
      • Cardiomyopathies
      • Heart failure
    • Dermatology

      Dermatology

      Browse overview
      • Atopic dermatitis
      • Hidradenitis suppurutiva
      • Psoriasis
      • Psoriatic arthritis
      • Scleroderma (systemic sclerosis)
      • Translational models in dermatology
    • Gastrointestinal diseases

      Gastrointestinal diseases

      Browse overview
      • CPa9-HNE (NordicCPa9-HNE™)—serum calprotectin
      • Inflammatory bowel disease (IBD)
      • Crohn’s disease
      • Ulcerative colitis
      • Intestinal fibrosis
      • Celiac disease
      • Eosinophilic esophagitis (EoE)
      • Translational models in IBD
    • Hepatic diseases

      Hepatic diseases

      Browse overview
      • Alcohol-related liver disease
      • End-stage liver disease
      • Enhanced Liver Fibrosis (ELF) Test
      • Immune-mediated liver diseases
      • MASLD, SLD, and MASH
      • Metabolic dysregulation
      • Viral liver diseases
      • Translational models in hepatic fibrosis
    • Kidney diseases

      Kidney diseases

      Browse overview
      • Chronic kidney disease (CKD)
      • IgA nephropathy (Berger’s disease)
      • Diabetic kidney disease (DKD)
      • Lupus nephritis
      • Translational models in kidney diseases
    • Neuroscience

      Neuroscience

      Browse overview
      • Alzheimer’s disease
      • Parkinson’s disease
      • Multiple sclerosis
    • Obesity

      Obesity

      Browse overview
      • Obesity
      • Diabetes
      • Enhanced Liver Fibrosis (ELF) Test
    • Oncology

      Oncology

      Browse overview
      • Immuno-oncology
      • Tumor fibrosis
      • Cancer-associated Fibroblasts (CAFs)
      • Translational models in cancer
    • Respiratory diseases

      Respiratory diseases

      Browse overview
      • Chronic respiratory diseases
      • ECLIPSE partnering project (COPD)
      • Pulmonary fibrosis
      • Translational models in pulmonary fibrosis
    • Rheumatic diseases

      Rheumatic diseases

      Browse overview
      • Axial spondyloarthritis (axSpA)
      • Osteoarthritis (OA)
      • Psoriatic arthritis
      • Rheumatoid arthritis (RA)
      • RheumaTrace™
      • Systemic lupus erythematosus (SLE)
      • Systemic sclerosis
      • Translational models in rheumatology
  • Laboratory Services
    • Biomarker Solutions

      Learn how Nordic ProteinFingerPrint™ biomarkers can support your pipeline.

      Visit this section
    • Biomarker Portfolio

      Find biomarkers and panels relevant to your study.

      Visit this section
    • Why Biomarkers?

      Learn how biomarkers in general can benefit drug development.

      Visit this section
    • Browse overview
    • Why choose our lab
    • Central lab services
    • Specialty lab solutions
    • Accreditations
    • Regulatory services
  • Technology
    • Biomarker Solutions

      Learn how Nordic ProteinFingerPrint™ biomarkers can support your pipeline.

      Visit this section
    • Biomarker Portfolio

      Find biomarkers and panels relevant to your study.

      Visit this section
    • Why Biomarkers?

      Learn how biomarkers in general can benefit drug development.

      Visit this section
    • Browse overview
    • Nordic ProteinFingerPrint Technology™
    • FIB-NIT™ biomarker panel
    • RheumaTrace™
    • NordicPRO-C3™ (PRO-C3)
    • CPa9-HNE (NordicCPa9-HNE™)—serum calprotectin
    • Translational models
  • About
    • Biomarker Solutions

      Learn how Nordic ProteinFingerPrint™ biomarkers can support your pipeline.

      Visit this section
    • Biomarker Portfolio

      Find biomarkers and panels relevant to your study.

      Visit this section
    • Why Biomarkers?

      Learn how biomarkers in general can benefit drug development.

      Visit this section
    • Browse overview
    • About us
    • News & events
    • Board of directors
    • Scientific leadership
    • Business development
    • Vision, mission & values
    • Career
  • Publications
  • Request a quote
  • Blog
  • Why Biomarkers?
  • Contact

2-Minute Science

Longitudinal Stability of Molecular Endotypes of Knee Osteoarthritis Patients

2-Minute Science

ECM Biomarkers Are Prognostic in Primary Cholangitis (PSC)

2-Minute Science

Rheumatoid Awareness Day 2025: Biomarkers in Rheumatoid Arthritis

2-Minute Science

World Cancer Day 2025: Biomarker Solutions in Cancer

2-Minute Science

Blood-Based Biomarkers in Pulmonary Fibrosis

2-Minute Science

ECM Biomarkers Can Assess Disease Burden and Treatment Response in Ulcerative Colitis (UC)

2-Minute Science

Hot and Cold Fibrosis

2-Minute Science

Monitoring Therapeutic Responses in Systemic Sclerosis (SSc)

2-Minute Science

Investigating Type IV Collagen Biomarkers in Multiple Sclerosis

Scientific Posters

BigH3 Is a Promising Biomarker in NSLC Patients

Scientific Posters

Tissue-Derived Peripheral Biomarkers (C4G, VICM, Cpa9-HNE) in Patients with Solid Tumors

Scientific Posters

myCAF Activity Can Be Assessed by Specific Collagen Pro-Peptide Biomarkers

Scientific Posters

IL1RAP Blockade Mediates Anti-Fibrotic Effects in Pancreatic Cancer-Associated Fibroblasts

Scientific Posters

ECM Turnover Biomarkers as Prognostic Tools in Immunotherapy for Solid Tumors

Scientific Posters

Unraveling Collagen Signatures in Cancer-Associated Fibroblasts

Scientific Posters

Investigating NordicPRO-C3™ as a Prognostic Biomarker in NSCLC Patients

Join our newsletter! Read by 4000+ researchers, drug developers, and academics.

Herlev Hovedgade 205

2730 Herlev

Denmark (VAT: DK30799968)

 

Subscribe to our newsletter!

Therapeutic areas

  • Cardiovascular diseases
  • Dermatology
  • Gastrointestinal diseases
  • Hepatic diseases
  • Kidney diseases
  • Neuroscience
  • Obesity and metabolic disorders
  • Oncology
  • Respiratory diseases
  • Rheumatic diseases

About

  • About us
  • News & events
  • Board of Directors
  • Scientific leadership
  • Alliance managers
  • Vision, mission & values
  • Career
  • Knowledge hub

Technology

  • The Nordic ProteinFingerPrint Technology™
  • The FIB-NIT™ Biomarker Panel
  • RheumaTrace™
  • CPa9-HNE (Serum Calprotectin)
  • Translational models
  • Biomarker portfolio
  • Whistleblower policy
  • Cookie policy
  • Privacy policy
  • Site disclaimer